The approval happened after participants in several GLP-1 trials experienced significant reductions in major cardiac crises, such as heart attacks and strokes, and fewer cardiovascular deaths, says Isaacs
Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al
A Guide to Weight-Loss Medications: Anti-obesity drugs, from older pills to the new GLP-1s Losing weight is hard to do
Extracellular Matrix and Tissue Remodeling The extracellular matrix provides the structural framework that supports tissues throughout the body
,
Tumor necrosis factor: a mechanistic link between angiotensin-IIinduced cardiac inflammation and fibrosis